These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25081827)

  • 41. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Majeed A; Roberts SK; Kemp W
    Gastroenterology; 2019 Mar; 156(4):1217. PubMed ID: 30543798
    [No Abstract]   [Full Text] [Related]  

  • 44. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S; Khan AA; Tarique S
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
    El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
    [No Abstract]   [Full Text] [Related]  

  • 46. Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option.
    Sangiovanni A; Colombo M
    Hepatology; 2011 Dec; 54(6):1898-900. PubMed ID: 21932397
    [No Abstract]   [Full Text] [Related]  

  • 47. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.
    Taketa K; Endo Y; Sekiya C; Tanikawa K; Koji T; Taga H; Satomura S; Matsuura S; Kawai T; Hirai H
    Cancer Res; 1993 Nov; 53(22):5419-23. PubMed ID: 7693340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
    Tayob N; Lok AS; Do KA; Feng Z
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):469-475.e2. PubMed ID: 26260109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
    Lee E; Edward S; Singal AG; Lavieri MS; Volk M
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
    Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
    Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
    Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
    Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
    Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
    Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum concentrations of tissue polypeptide antigen and alpha 1-fetoprotein in patients with primary liver cancer, liver metastasis and liver cirrhosis].
    Polterauer P; Legenstein E; Müller M
    Wien Klin Wochenschr; 1985 Apr; 97(9):417-20. PubMed ID: 2408389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
    Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
    Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
    Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
    Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.